Buy APO-DICLO SR 75 MG DICLOFENAC SODIUM

APO-DICLO SR 75 MG is an extended-release tablet containing diclofenac sodium, used for managing pain and inflammation. This medication is designed for oral administration and is manufactured by Apotex Inc in Canada.

Strength

75 MG

Pack Size

100/500

Manufacturer / TM Owner

APOTEX INC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Uses / Indications

APO-DICLO SR 75 MG is commonly used for the relief of pain and inflammation associated with various conditions. Diclofenac sodium, the active ingredient, is often prescribed for what is diclofenac used for, including musculoskeletal disorders and arthritis. This extended-release formulation is intended to provide prolonged relief, making it suitable for conditions requiring sustained management.

Side Effects

Common effects of APO-DICLO SR 75 MG may include reduced pain and inflammation. Some individuals might experience mild gastrointestinal discomfort or dizziness. As with any medication, effects can vary, and it is important to monitor for any adverse reactions.

Precautions & Warnings

APO-DICLO SR 75 MG should be handled with care, especially by individuals with a history of stomach ulcers or bleeding disorders. It is advisable to follow the prescribed dosage and administration instructions provided by a healthcare professional. Always store the medication in a cool, dry place away from direct sunlight.

Avoid Interactions

Diclofenac sodium may interact with other medications, including blood thinners, diuretics, and certain antidepressants. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Additionally, alcohol consumption should be limited while using this medication.

References

Frequently Asked Questions

APO-DICLO SR 75 MG is used for the relief of pain and inflammation, often associated with musculoskeletal disorders and arthritis.

APO-DICLO SR 75 MG is an oral extended-release tablet that should be taken as directed by a healthcare professional.

Common side effects may include mild gastrointestinal discomfort or dizziness. Always consult a healthcare provider for personalized advice.

Diclofenac sodium may interact with other medications, so it is important to inform your healthcare provider about all medications you are taking.

APO-DICLO SR 75 MG is manufactured by Apotex Inc in Canada.

Published by GNH India Pharmaceuticals Limited

Last updated: 17 Jun 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.